In this free webinar, learn how osmolality testing supports the diagnosis and management of diabetes insipidus (DI). Attendees will gain insight into how serum osmolality and body weight measurements are used to proceed with a water deprivation test safely. The featured speaker will discuss how urine osmolality is used to assess a patient's capacity for concentrating urine to diagnose diabetes insipidus. Attendees will learn how urine osmolality is used to differentiate the etiology of suspected diabetes insipidus after desmopressin.
TORONTO, Oct. 23, 2025 /PRNewswire/ -- The diagnosis of diabetes insipidus (DI) hinges on the careful assessment of the body's ability to concentrate urine in response to water deprivation. Among the array of diagnostic tools available, osmolality testing plays a pivotal role in distinguishing central and nephrogenic DI from primary polydipsia and other causes of polyuria.
By systematically monitoring changes in serum and urine osmolality during the water deprivation test, clinicians can precisely evaluate renal concentrating capacity and antidiuretic hormone (ADH) responsiveness. This process not only enhances diagnostic specificity but also informs subsequent therapeutic strategies, ultimately leading to improved patient outcomes. The incorporation of osmolality measurements into water deprivation protocols ensures a robust, safe, evidence-based approach for the nuanced diagnosis of DI.
This webinar will guide attendees through the structured application of osmolality data during each phase of the water deprivation test. It will cover how clinicians interpret serum and urine values to determine when testing should proceed or stop, how urine concentration patterns inform diagnosis and how response to desmopressin provides critical clues for distinguishing underlying etiologies.
Register for this webinar to learn how osmolality testing supports the diagnosis and management of DI.
Join Dr. Arian Gower, MD, Nephrologist, Renal Consultants Medical Group, for the live webinar on Tuesday, November 11, 2025, at 2pm EST (11am PST).
For more information, or to register for this event, visit Osmolality as a Key to Diagnosing Diabetes Insipidus.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

Newsrooms &
Influencers

Digital Media
Outlets

Journalists
Opted In
Share this article